| [1] |
chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al..
Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with
[J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
|
| [2] |
Shi Yingying, Wang Yuanxi..
Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
|
| [3] |
patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al..
Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in
[J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
|
| [4] |
Wu Dan Ma Xiangying..
Insulin resistance,carotid atherosclerosis and left ventricular function in patients with NAFLD-induced liver cirrhosis
[J]. Journal of Practical Hepatology, 2019, 22(6): 876-879.
|
| [5] |
Gao Wei, Hou Yong.
Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
|
| [6] |
Bai Yichun, Deng Jihong, Mei Xiaoping.
Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
|
| [7] |
Zhang Yafei, Ye Jun, Xie Qinxiu, et al.
Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
|
| [8] |
Wang Baodan, Li Meng, Gao Yu.
Predictive factors of response to interferon-α antiviral therapy in children with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 345-348.
|
| [9] |
Jiang Yi, Liu Bing.
Comparison of clinical features and histopathological activity index between patients with chronic hepatitis B and chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 188-191.
|
| [10] |
Zhang Huanhuan, Yang Huan, Shen Silan, et al..
Distribution of HBV genotypes and drug-resistant mutations in patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 41-44.
|
| [11] |
Xu Jing, Tao Linlin, Ye Jiaojiao, et al..
Impact of terbivudine combined with adefovir dipivoxil therapy on renal functions in patients with decompensated hepatitis B liver cirrhosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 89-92.
|
| [12] |
Hu Hulan, Zhu Mengfei, Shi Junping..
Non-alcoholic fatty liver disease with concurrent chronic hepatitis B: What’s the progress
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(1): 149-152.
|
| [13] |
Wang Yaofeng..
Efficacy and safety of tenofovir in the treatment of patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 847-850.
|
| [14] |
Huang Chunming, Yang Zhan, Nie Yuqiang, et al..
Prediction of liver fibrosis by gamma-glutamyl-transpeptidase-to-platelet ratio in patients with chronic hepatitis B viral infection with normal serum transaminase levels
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 859-862.
|
| [15] |
Huang Faguang, Li Xiaocheng, Gong Jianping, et al..
Research on insulin resistance related protein molecules in human liver tissues by comprehensive gene expression profiling analysis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 872-876.
|
